Price loading...

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
30 September 2015
Listed Since
02 June 2016

Similar Products You Might Like

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
99% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 11 Jan 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
98% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China

£595.00 10 Mar 2026
The 2021-2026 World Outlook for Lung Cancer Therapeutics
97% match

The 2021-2026 World Outlook for Lung Cancer Therapeutics

£795.00 12 Jan 2026
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
97% match

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

£595.00 25 Jan 2026
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in the United States

£595.00 28 Feb 2026
The 2016-2021 Outlook for Liver Cancer Drugs in the United States
97% match

The 2016-2021 Outlook for Liver Cancer Drugs in the United States

£595.00 11 Jan 2026
The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in the United States
97% match

The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in the United States

£595.00 10 Dec 2025
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
97% match

The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States

£595.00 14 Jan 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
96% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 08 Jan 2026
The 2016-2021 Outlook for Erythropoietins in the United States
96% match

The 2016-2021 Outlook for Erythropoietins in the United States

£595.00 01 Feb 2026
The 2016-2021 Outlook for Lou Gehrig's Disease Drugs in the United States
96% match

The 2016-2021 Outlook for Lou Gehrig's Disease Drugs in the United States

£595.00 25 Jan 2026
The 2016-2021 Outlook for Tobacco and Non-Tobacco Cigarettes in the United States
96% match

The 2016-2021 Outlook for Tobacco and Non-Tobacco Cigarettes in the United States

£595.00 12 Jan 2026
The 2016-2021 Outlook for Linear Accelerators for Radiation Therapy in the United States
96% match

The 2016-2021 Outlook for Linear Accelerators for Radiation Therapy in the United States

£595.00 13 Jan 2026
The 2016-2021 Outlook for Pulmonary Drug Delivery Systems in the United States
96% match

The 2016-2021 Outlook for Pulmonary Drug Delivery Systems in the United States

£595.00 30 Jan 2026
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
96% match

The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East

£325.00 13 Dec 2025
The 2016-2021 Outlook for Small Molecule Kinase Inhibitors in the United States
96% match

The 2016-2021 Outlook for Small Molecule Kinase Inhibitors in the United States

£595.00 10 Dec 2025
The 2016-2021 Outlook for Nanomedicine in the United States
96% match

The 2016-2021 Outlook for Nanomedicine in the United States

£595.00 23 Jan 2026
The 2016-2021 Outlook for Stem Cell Products in the United States
96% match

The 2016-2021 Outlook for Stem Cell Products in the United States

£595.00 05 Feb 2026
The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in the United States
96% match

The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in the United States

£595.00 25 Jan 2026
The 2016-2021 Outlook for Bladder Cancer Therapeutics in Japan
96% match

The 2016-2021 Outlook for Bladder Cancer Therapeutics in Japan

£595.00 01 Feb 2026
The 2016-2021 Outlook for Phytosterols in the United States
96% match

The 2016-2021 Outlook for Phytosterols in the United States

£595.00 22 Jan 2026
The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan
96% match

The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan

£595.00 08 Mar 2026
The 2016-2021 Outlook for Astaxanthin in the United States
96% match

The 2016-2021 Outlook for Astaxanthin in the United States

£595.00 25 Jan 2026
The 2021-2026 World Outlook for Circulating Tumor Cell (CTC) Technologies
96% match

The 2021-2026 World Outlook for Circulating Tumor Cell (CTC) Technologies

£795.00 13 Dec 2025